Changing the Child : The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental Disorders
Bioethics · 2026-06 · 40 (5) · 482-490
DOI: 10.1111/bioe.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioethics, online erschienen am 15.05.2026. Verfasst von Sietske A L van Till und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Program for Medical Ethics, Philosophy and History of Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterd…. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Parents, Craniofacial Abnormalities, Heart Defects, Congenital. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development, ZonMw.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Scientific advancements offer new possibilities for developing novel treatments for children with monogenic neurodevelopmental disorders (mNDDs), targeting the underlying effects of their condition. Although, in qualitative studies, parents of children with mNDDs have predominantly positive attitudes towards the development of novel treatments, a few parents express concerns about whether treatments could change who their child is . Existing literature on personal identity, including literature on how personal identity is affected by medical (neuro‐)interventions, can assist in clarifying these concerns. This paper provides an analysis of interview data on perspectives of parents with children with mNDDs (STXBP1‐Related Disorders and Kleefstra Syndrome) on the impact of novel treatments on their child's identity. We identify four sets of concerns, about whether treatments (1) enable children to develop their self, (2) alienate children from their true self, (3) disrupt children's relational identities, and (4) defy children's horizontal identities. While parents hope that treatments will help children flourish, some worry that treatments may alienate children from their self or alter children's personal characteristics which are meaningful to caregivers, thereby disrupting family dynamics. Others fear treatments may produce stigma by perpetuating the narrative that children need to be “fixed”. This analysis helps to understand the ambivalence some parents express when considering their child's participation in clinical trials. For clinicians and researchers, it is essential to discuss parents' concerns about impacts of treatments on their child's identity (if present) when deciding on the child's participation in clinical trials, and to monitor children for identity‐related effects of novel treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health, Program for Medical Ethics, Philosophy and History of Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
- Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
- N=You Neurodevelopmental Precision Center, Amsterdam Neuroscience, Amsterdam Reproduction and Development, Amsterdam UMC, Amsterdam, the Netherlands.
- Department of Child and Adolescent Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Levvel, Center for Child and Adolescent Psychiatry, Amsterdam, the Netherlands.
- Child and Adolescent Psychiatry and Psychosocial Care, Emma Children's Hospital, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
ORCID-Profile: Sietske A L van Till, Maartje H N Schermer, Hilgo Bruining, Matthijs Verhage, Eline M Bunnik
Förderung
- Netherlands Organisation for Health Research and Development
- ZonMw
Zitieren
APA
van Till, S. A. L., Schermer, M. H. N., Bruining, H., Verhage, M., & Bunnik, E. M. (2026). Changing the Child : The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental Disorders. Bioethics, 40(5), 482-490. https://doi.org/10.1111/bioe.70119
Vancouver
van Till SAL, Schermer MHN, Bruining H, Verhage M, Bunnik EM. Changing the Child : The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental Disorders. Bioethics. 2026;40(5):482-490. doi:10.1111/bioe.70119
BibTeX
@article{vanTill2026,
author = {van Till, Sietske A L and Schermer, Maartje H N and Bruining, Hilgo and Verhage, Matthijs and Bunnik, Eline M},
title = {Changing the Child : The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental Disorders},
journal = {Bioethics},
year = {2026},
volume = {40},
number = {5},
pages = {482--490},
doi = {10.1111/bioe.70119}
}
EUVIMED